Haemoglobinopathies congenital Completed Phase 3 Trials for Hydroxyurea (DB01005)

Also known as: Hemoglobinopathy / Haemoglobinopathies / Hemoglobinopathies / Haemoglobinopathy / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000586Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)Treatment